[Federal Register Volume 65, Number 86 (Wednesday, May 3, 2000)]
[Notices]
[Page 25734]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-10981]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 DAY-25-00]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-7090. Send written 
comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
Executive Office Building, Room 10235; Washington, DC 20503. Written 
comments should be received within 30 days of this notice.

Proposed Projects

    1. Surveillance and Evaluation of Blood Donors Positive for Human 
Immunodeficiency Virus (HIV) Antibody or HIV Antigen (0920-0329)--
Extension--National Center for HIV, STD, and TB Prevention (NCHSTP). In 
1987, the President directed the Department of Health and Human 
Services (DHHS) to determine the nationwide incidence of, to predict 
the future of, and to determine the extent to which human 
immunodeficiency virus (HIV) is present in various segments of our 
population. In response, CDC formed an epidemiological team to 
summarize existing information. An extensive review of published and 
unpublished data led to the conclusion that even though there is 
information suggesting a very large number of Americans were infected, 
there was no substitute for carefully and scientifically obtained 
incidence and prevalence data. The need to monitor HIV seroprevalence 
existed on the national and at the state and local levels for public 
health management: targeting and evaluating prevention programs, 
planning future health care needs and determining health policy.
    On a national basis, HIV seroprevalence projects in 1987 consisted 
of monitoring the HIV status of: Civilian applicants for military 
service; blood donors, including follow-up risk factor evaluation in 
seropositives; and Job Corps entrants. HIV prevalence was studied in 
settings of special public health interest including selected colleges 
and prisons, among health care workers in hospital emergency rooms and 
among Native Americans and homeless persons. Other national data 
sources were examined, such as cohort studies of groups at risk, 
including homosexual and bisexual men and IV drug users, providing 
information on knowledge of AIDS and risk behaviors, changes in 
behavior, and incidence of HIV infection.
    In 1987, OMB approved the Family of HIV Seroprevalence Surveys 
(0920-0232). These surveys included seven seroprevalence surveys that 
involved interaction with individuals (non-blinded surveys). One of 
these surveys was the surveillance and evaluation of blood donors.
    The objectives of this study are to: (1) Estimate the prevalence 
and incidence of HIV infection among blood donors at participating 
blood centers; (2) evaluate the characteristics of infected donors to 
strengthen the effectiveness of the donor screening and deferral 
processes; (3) analyze the risk behavior characteristics of infected 
donors to assess distribution and trends of HIV; (4) monitor additional 
human immunodeficiency viruses, HIV genetic variation, and other 
infections relevant to the epidemiology of HIV among U.S. blood donors 
and seroconverted recipients; (5) estimate the risk of HIV transmission 
from screened blood; (6) and evaluate new tests to decrease 
transmission by window period donors.
    In 1993 and 1996, OMB again approved for 3 years each, the 
surveillance and evaluation of blood donors who test positive for Human 
Immunodeficiency Virus (HIV) Antibody and their needle-sharing and 
sexual partners (0920-0329). This request is for an additional 3-year 
approval. The CDC anticipates 125 positive donors will enroll annually 
in this study (based upon previous 3 year enrollment rates and 
epidemiological progress of the disease). The interview takes 
approximately 1 hour to complete for those who agree to the interview 
and 10 minutes to complete for those who refuse to enroll. The Annual 
Burden is 140.

----------------------------------------------------------------------------------------------------------------
                                                                                      No. of        Avg. burden
                           Respondents                                No. of        responses/     response (in
                                                                    respondents     respondent        hours)
----------------------------------------------------------------------------------------------------------------
Blood donors (interviewed)......................................             125               1             1.0
Blood donors (refuse interview).................................              92               1           10/60
----------------------------------------------------------------------------------------------------------------


    Dated: April 26, 2000.
Charles W. Gollmar,
 Acting Associate Director for Policy, Planning, and Evaluation, 
Centers for Disease Control and Prevention (CDC).
[FR Doc. 00-10981 Filed 5-2-00; 8:45 am]
BILLING CODE 4163-18-P